Lung Cancer Trial, Not Yet Recruiting NCT07277088 Sponsor: Jiayuan Sun Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07277088
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 80 years old, of any gender.
  • People who have lung nodules found on a chest CT scan that are suspected to be cancerous and that the researchers have determined need a needle biopsy to get a clear diagnosis.
  • People whose lung nodule measures more than 8mm but no more than 30mm at its longest point.
  • People who have signed the consent form and are willing to take part in the study voluntarily.
  • People who are able to understand the study, cooperate with its procedures, and attend follow-up appointments as required.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a blood clotting problem that cannot be corrected, an infection along the path where the needle would be inserted, a nodule that is too close to organs or major blood vessels, a suspected parasitic lung cyst (echinococcosis) on scans, a need for mechanical breathing support (a ventilator), a liver condition called multilocular echinococcosis, or who are in a coma or otherwise unable to cooperate.
  • People who the investigators determine are not suitable for a chest needle biopsy due to conditions such as severe high blood pressure in the lungs, large air pockets in the lungs (bullae), chronic obstructive pulmonary disease (COPD), emphysema, or lung scarring (pulmonary fibrosis).
  • People who are in poor overall health, such as those with cancer that has spread widely through the body, severe infection, high fever, significant weight loss and muscle wasting (cachexia), serious failure of major organs, or severe anaemia and nutritional problems that cannot be improved quickly.
  • People who are allergic to contrast dyes or anaesthetic medicines.
  • People who have a pacemaker implanted.
  • People who are pregnant, breastfeeding, or planning to become pregnant during the trial.
  • People who are unable to cooperate with the procedure due to known drug or alcohol dependency, mental health or neurological conditions, intellectual disability, or psychological disorders.
  • People who are currently taking part in another clinical trial of a drug (within the past 3 months) or a medical device (within the past 1 month).
  • People whose lung nodule has already been diagnosed or has already received treatment.
  • People who the investigator considers unsuitable for the trial for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-021-22200000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Jiayuan Sun
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
30 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Dianostic yield

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov